Chemo-radiotherapy in Adjuvant Therapy of Curatively Resected Pancreatic Cancer: Lesions from TCOG T3207 Study

被引：5
|
作者：
Chen, Li-Tzong [1 ]
机构：
[1] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Township, Taiwan
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
10.1093/annonc/mdz354
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DL16
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [1] Adjuvant Chemo-Radiotherapy for Resectable Pancreatic Head Cancer: The Real Benefit of Radiation Therapy
    Masi, A.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S153 - S153
  • [2] Adjuvant chemo-radiotherapy for gastric cancer: A pilot study
    Capello, C
    Alabiso, O
    Satolli, MA
    Ricardi, U
    Malossi, A
    Moro, F
    Destefanis, M
    Porcile, GF
    ANNALS OF ONCOLOGY, 1998, 9 : 55 - 55
  • [3] Adjuvant combination therapy with gemcitabine and autologous γδ T-cell transfer in patients with curatively resected pancreatic cancer
    Aoki, Taku
    Viatsushita, Hirokazu
    Hoshikawa, Mayumi
    Hasegawa, Kiyoshi
    Kokudo, Norihiro
    Kakimi, Kazuhiro
    CYTOTHERAPY, 2017, 19 (04) : 473 - 485
  • [4] Necessity of adjuvant concurrent chemo-radiotherapy in D2-resected LN-positive gastric cancer
    Yu, Jeong Il
    Lim, Do Hoon
    Lee, Jeeyun
    Kang, Won Ki
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kim, Seung Tae
    Lee, Su Jin
    Kim, Sung
    Sohn, Tae Sung
    Lee, Jun Ho
    An, Ji Yeong
    Choi, Min Gew
    Bae, Jae Moon
    Kim, Hye Seung
    Ahn, Soohyun
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) : 306 - 312
  • [5] High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy
    S Papagrigoriadis
    British Journal of Cancer, 2006, 95 : 950 - 950
  • [6] High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy
    Papagrigoriadis, S.
    BRITISH JOURNAL OF CANCER, 2006, 95 (07) : 950 - 950
  • [7] IS THERE A BENEFIT FROM ADJUVANT CHEMO-RADIOTHERAPY FOR THE PATIENTS WITH RESECTABLE GASTRIC CANCER? RESULTS OF THE STANDARDIZED MULTIMODAL TREATMENT
    Gajzer, Borut
    Potrc, Stojan
    Ivanecz, Arpad
    Horvat, Matjaz
    ANNALS OF ONCOLOGY, 2011, 22 : v51 - v52
  • [8] Surgically Staged High-Risk Endometrial Cancer: Randomized Study of Adjuvant Radiotherapy Alone vs. Sequential Chemo-Radiotherapy
    Kuoppala, Tapio
    Maenpaa, Johanna
    Tomas, Eija
    Puistola, Ulla
    Salmi, Tuula
    Grenman, Seija
    Lehtovirta, Pentti
    Fors, Matti
    Luukkaala, Tiina
    Sipila, Pirkko
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2008, 63 (11) : 703 - 704
  • [9] Surgically staged high-risk endometrial cancer:: Randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy
    Kuoppala, Tapio
    Maenpaa, Johanna
    Tomas, Eija
    Puistola, Ulla
    Salmi, Tuula
    Grenman, Seija
    Lehtovirta, Pentti
    Fors, Matti
    Luukkaala, Tiina
    Sipilae, Pirkko
    GYNECOLOGIC ONCOLOGY, 2008, 110 (02) : 190 - 195
  • [10] Phase II Study of Gemcitabine and Erlotinib as Adjuvant Therapy for Patients with Resected Pancreatic Cancer
    Bao, Philip Q.
    Ramanathan, Ramesh K.
    Krasinkas, Alyssa
    Bahary, Nathan
    Lembersky, Barry C.
    Bartlett, David L.
    Hughes, Steven J.
    Lee, Kenneth K.
    Moser, A. James
    Zeh, Herbert J., III
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (04) : 1122 - 1129
12345